Non-Small Cell Lung Cancer Clinical Trial 20203077

[LCID Study Number: 20203077]

S1914: A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC

The purpose of this study is to evaluate treatment with atezolizumab added to standard radiation therapy in patients with stage I-IIA non-small cell lung cancer (NSCLC).

Disease/Condition: Non-Small Cell Lung Cancer

Department: Hematology and Oncology

Location(s): Beverly Hospital; Lahey Hospital & Medical Center (Burlington); Lahey Medical Center, Peabody; Winchester Hospital

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-3421

View NCT ID 04214262 on ClinicalTrials.gov
Protocol #: 20203077
Principal Investigator(s): Paul J. Hesketh
Study Coordinator(s): Julia Roache
Trial Phase: Sponsor Initiated Study Phase 3